Medtronic Plc Quick Ratio (MDT) starting from the first quarter 2026 to first quarter 2025, Financial Strength Trends, Rankings, Financial Ratios - CSIMarket
CSIMarket
 


Medtronic Plc  (NYSE: MDT)

Medtronic Plc's Quick Ratio

MDT's quarterly Quick Ratio and Cash & cash equivalent, Current Liabilities growth


Medtronic Plc's Cash & cash equivalent grew by 72.53 % in the Q1 2026 sequentially, faster than Current Liabilities, this led to improvement in Medtronic Plc's Quick Ratio to 1.36, Quick Ratio remained below Medtronic Plc average.

Within Medical Equipment & Supplies industry 108 other companies have achieved higher Quick Ratio than Medtronic Plc in first quarter 2026. While Quick Ratio total ranking in the first quarter 2026 has deteriorated compared to the prior quarter from 784 to 1849.

Explain Quick Ratio?
How much Cash & cash equivalents MDT´s has?
What are MDT´s Current Liabilities?




MDT Quick Ratio (Jul 31 2026)
Q1
(Apr 24 2026)
Q4
(Jan 23 2026)
Q3
(Oct 24 2025)
Q2
(Jul 25 2025)
Q1
Y / Y Current Liabilities Change 2.33 % -9.48 % 19.37 % -18.53 % 12.08 %
Y / Y Cash & cash equivalent Change 97.86 % 2.44 % 11.99 % 4.23 % 3.54 %
Quick Ratio MRQ 1.36 0.8 0.7 0.84 0.7
MDT's Total Ranking # 1849 # 784 # 1703 # 1730 #
Seq. Current Liabilities Change 1.21 % -9.48 % 29.63 % -13.83 % -10.47 %
Seq. Cash & cash equivalent Change 72.53 % 3.88 % 7.66 % 2.54 % -10.67 %



Quick Ratio first quarter 2026 Company Ranking
Within: No.
Medical Equipment & Supplies Industry # 109
Healthcare Sector # 632
Overall Market # 1849


Quick Ratio Statistics
High Average Low
465.7 6.46 0.35
(Jan 23 2015)   (Jan. 25. 2013)




Financial Statements
Medtronic Plc's Current Liabilities $ 11,799 Millions Visit MDT's Balance sheet
Medtronic Plc's Cash & cash equivalent $ 16,068 Millions Visit MDT's Balance sheet
Source of MDT's Sales Visit MDT's Sales by Geography


Cumulative Medtronic Plc's Quick Ratio

MDT's Quick Ratio for the trailling 12 Months

MDT Quick Ratio

(Jul 31 2026)
12 Months
(Apr 24 2026)
12 Months
(Jan 23 2026)
12 Months
(Oct 24 2025)
12 Months
(Jul 25 2025)
12 Months
Y / Y Current Liabilities TTM Growth -2.37 % -0.32 % 3.66 % 3.01 % 14.81 %
Y / Y Cash & cash equivalent TTM Growth 28.51 % 5.46 % 7.49 % 4.65 % 4.42 %
Quick Ratio TTM 0.92 0.75 0.73 0.74 0.7
Total Ranking TTM # 4695 # 2950 # 2918 # 2862 #
Seq. Current Liabilities TTM Growth 0.58 % -2.59 % 4.63 % -4.77 % 2.69 %
Seq. Cash & cash equivalent TTM Growth 22.88 % 0.64 % 2.86 % 1.02 % 0.84 %


On the trailing twelve months basis MDT Cash & cash equivalent soared by 97.86 % in Q1 2026 year on year, faster than Current Liabilities, this led to increase in in Medtronic Plc's Quick Ratio to 0.92, Quick Ratio remained below MDT average.
Quick Ratio is the average cumulative value over the last four quarters.

Among companies operating within Medical Equipment & Supplies industry 218 other companies have achieved higher Quick Ratio than Medtronic Plc. While Quick Ratio total ranking has deteriorated compared to the previous twelve months ending in the fourth quarter 2026 from 2950 to 4695.

Explain Quick Ratio?
How much Cash & cash equivalents MDT´s has?
What are MDT´s Current Liabilities?

TTM Quick Ratio Company Ranking
Within: No.
Within the Medical Equipment & Supplies Industry # 219
Healthcare Sector # 998
Within the Market # 4695


trailing twelve months Quick Ratio Statistics
High Average Low
3.37 1.09 0.4
(Oct 30 2015)   (Jan. 25. 2013)




Companies with similar Quick Ratio in the quarter ending Jul 31 2026, within Medical Equipment & Supplies Industry Quick RatioJul 31 2026 MRQ Cash & cash equivalentJul 31 2026 MRQ Current Liabilities
Logicmark Inc  3.71 $ 6.596  Millions$ 1.779  Millions
Axogen inc   3.67 $ 111.412  Millions$ 30.374  Millions
Procept Biorobotics Corporation  3.60 $ 230.952  Millions$ 64.196  Millions
Heartbeam Inc   3.54 $ 8.700  Millions$ 2.460  Millions
Mimedx Group Inc   3.53 $ 135.839  Millions$ 38.498  Millions
Sensus Healthcare Inc   3.51 $ 15.186  Millions$ 4.327  Millions
Outset Medical Inc   3.35 $ 147.194  Millions$ 43.891  Millions
Inspiremd Inc   3.15 $ 30.421  Millions$ 9.646  Millions
Fractyl Health Inc   3.00 $ 47.140  Millions$ 15.736  Millions
Vivani Medical Inc   2.99 $ 19.894  Millions$ 6.659  Millions
Retractable Technologies Inc  2.98 $ 39.870  Millions$ 13.365  Millions
Neuropace Inc   2.97 $ 51.700  Millions$ 17.433  Millions
Apyx Medical Corp  2.95 $ 27.617  Millions$ 9.354  Millions
Omada Health Inc   2.94 $ 221.712  Millions$ 75.483  Millions
Clearpoint Neuro Inc   2.85 $ 29.363  Millions$ 10.313  Millions
Penumbra Inc  2.82 $ 658.795  Millions$ 233.776  Millions
Glaukos Corp  2.80 $ 286.594  Millions$ 102.329  Millions
Pulmonx Corporation  2.76 $ 56.393  Millions$ 20.405  Millions
Intuitive Surgical Inc   2.71 $ 5,216.200  Millions$ 1,922.900  Millions
Neuraxis Inc   2.69 $ 8.342  Millions$ 3.096  Millions
Edwards Lifesciences Corporation  2.68 $ 4,291.700  Millions$ 1,604.100  Millions
Modular Medical Inc  2.63 $ 3.920  Millions$ 1.489  Millions
Co diagnostics Inc   2.55 $ 7.299  Millions$ 2.863  Millions
Staar Surgical Co  2.47 $ 181.489  Millions$ 73.394  Millions
Electromed Inc   2.35 $ 20.450  Millions$ 8.714  Millions
EBR Systems, Inc.  2.18 $ 113.533  Millions$ 52.023  Millions
Medinotec Inc   2.15 $ 2.519  Millions$ 1.171  Millions
Atricure Inc   2.05 $ 167.786  Millions$ 81.916  Millions
Tactile Systems Technology Inc   1.83 $ 69.853  Millions$ 38.253  Millions
Tandem Diabetes Care Inc   1.80 $ 455.996  Millions$ 253.005  Millions

Date modified: 2026-09-26T07:25:11+00:00



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.